Effect of conbercept or ranibizumab in the treatment of wet age-related macular degeneration
Objective: The aim of this study was to investigate the effects of conbercept or ranibizumab in the treatment of wet age-related macular degeneration (AMD) and to explore the influence on central retinal thickness (CRT), visual acuity, and choroidal neovascularization (CNV) permeation. Patients and...
Main Authors: | Dawei Zhang, Zahrah Khan, Tao Chai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Environmental Disease |
Subjects: | |
Online Access: | http://www.environmentmed.org/article.asp?issn=2468-5690;year=2019;volume=4;issue=2;spage=50;epage=54;aulast=Zhang |
Similar Items
-
Comparison of efficacy between Ranibizumab and Conbercept for wet age-related macular degeneration
by: Qiang Fan, et al.
Published: (2018-08-01) -
Clinical effect of Conbercept to improve visual acuity of patients with wet age-related macular degeneration
by: Zhen-Liu Zhu, et al.
Published: (2015-11-01) -
A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal
by: Rufino Silva, et al.
Published: (2017-06-01) -
Curative effect of different drugs in treatment of senile wet macular degeneration
by: Zhi-Qin Zhang, et al.
Published: (2017-06-01) -
Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review
by: Wei-Shai Liu, et al.
Published: (2019-09-01)